Skip to main content

Table 1 Consumption in defined daily dose per 1000 psychiatric inpatients per day of ten atypical antipsychotics covered by Israel’s national health care system, 2004 - 2013

From: Trends in the use of antipsychotics in the Israeli inpatient population, 2004–2013

 

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

Olanzapine

48.31

44.69

65.79

55.85

55.14

64.48

47.39

58.04

89.50

79.57

Clozapine

34.87

27.03

45.02

28.44

30.08

41.07

31.59

38.40

44.85

40.22

Quetiapine

9.74

17.01

21.60

20.73

24.90

32.04

28.63

28.71

45.97

43.04

Risperidone

21.61

26.86

26.37

33.99

23.35

25.16

19.52

19.86

23.02

17.79

Paliperidone

     

1.34

3.42

5.26

14.79

11.98

Aripiprazole

       

4.04

5.53

5.90

Iloperidone

         

0.03

Amisulpride

5.54

6.03

8.57

7.71

9.41

9.33

11.29

16.92

23.92

20.38

Ziprasidone

8.02

4.77

3.42

3.18

3.53

3.28

3.24

4.20

2.46

2.69

Sertindole

    

0.36

1.01

0.35

0.11

0.24

0.11

Total

128.1

126.4

170.8

149.9

146.8

177.7

145.4

175.5

250.3

221.7

  1. The blanks correspond to the periods in which the drugs were not marketed